Flumazenil acid
Based on 1 Customer Validation
Flumazenil acid is a metabolite of Flumazenil. Flumazenil is a GABAA receptor antagonist.
For research use only. We do not sell to patients.
- Purity: 99.96%
- CAS No.: 84378-44-9
- Formula: C13H10FN3O3
- Molecular Weight:275.24
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Chemical Information
-
CAS No. 84378-44-9
-
Appearance Solid
-
Molecular Weight 275.24
-
Formula C13H10FN3O3
-
Color Off-white to light yellow
-
SMILES
O=C(O)C1=C(N(C2=CC=C(C=C2C3=O)F)C=N1)CN3C
-
Synonyms
Ro 15-3890
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 100 mg/mL (363.32 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kleingeist B, et al. Isolation and pharmacological characterization of microsomal human liver flumazenil carboxylesterase. J Pharm Pharm Sci. 1998 Jan-Apr;1(1):38-46. [Content Brief]
[2]. Mograbi KM, et al. Effects of GABAa receptor antagonists on motor behavior in pharmacological Parkinson's disease model in mice. Physiol Rep. 2017 Mar;5(6). pii: e13081. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.6332 mL | 18.1660 mL | 36.3319 mL | 90.8298 mL |
| 5 mM | 0.7266 mL | 3.6332 mL | 7.2664 mL | 18.1660 mL | |
| 10 mM | 0.3633 mL | 1.8166 mL | 3.6332 mL | 9.0830 mL | |
| 15 mM | 0.2422 mL | 1.2111 mL | 2.4221 mL | 6.0553 mL | |
| 20 mM | 0.1817 mL | 0.9083 mL | 1.8166 mL | 4.5415 mL | |
| 25 mM | 0.1453 mL | 0.7266 mL | 1.4533 mL | 3.6332 mL | |
| 30 mM | 0.1211 mL | 0.6055 mL | 1.2111 mL | 3.0277 mL | |
| 40 mM | 0.0908 mL | 0.4541 mL | 0.9083 mL | 2.2707 mL | |
| 50 mM | 0.0727 mL | 0.3633 mL | 0.7266 mL | 1.8166 mL | |
| 60 mM | 0.0606 mL | 0.3028 mL | 0.6055 mL | 1.5138 mL | |
| 80 mM | 0.0454 mL | 0.2271 mL | 0.4541 mL | 1.1354 mL | |
| 100 mM | 0.0363 mL | 0.1817 mL | 0.3633 mL | 0.9083 mL |